Lawmakers will likely have a lot to say about health care this year. Paradoxically, they probably won't accomplish much on ...

A provocative new proposal has offered the FDA a way to let a broad swath of potentially risky AI devices flood the market.

Business is booming for Trump-connected lobbying firms as pharma giants see new opportunity to influence the FDA.

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

A handful of states are considering initiatives to increase funding for scientific research as uncertainty around federal ...

Federal officials have missed the legal deadline to notify the public of an upcoming ACIP meeting, raising questions about ...

As smoking rates fall in the U.S., startups and influencers are pushing the purported cognitive and health benefits of ...

In a time of uncertainty, the public health campaign to save the CDC Injury Center offers important lessons — and hope.

Joe Sachs, a physician and executive producer on “The Pitt,” and the CEO of Undue Medical Debt weigh in on the show’s foray ...

Some GLP-1 patients are begging to stay on the drugs just a little bit longer, presenting an ethical dilemma for doctors.

The top drug regulator at the FDA told staff she plans to question the safety of taking SSRIs in pregnancy and of RSV shots ...

Rick Abramson, formerly a chief medical officer at a subsidiary of Harrison.ai, which develops AI products to interpret ...